Covered recipient · General Payments record
MEGAN R BACALL
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,424.85
- Reported across 63 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $498.84 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $320.51 | 19 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $47.00 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.60 | 1 |
| PFIZER INC. | $25.44 | 1 |
| Kerecis Limited | $25.11 | 1 |
| LEO Pharma Inc. | $21.14 | 1 |
| Galderma Laboratories, L.P. | $17.69 | 1 |
| Amgen Inc. | $13.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.50 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359745 | CMS |
| ABBVIE INC. | $25.43 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359747 | CMS |
| ABBVIE INC. | $9.58 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359749 | CMS |
| ABBVIE INC. | $14.70 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359751 | CMS |
| ABBVIE INC. | $19.92 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359753 | CMS |
| ABBVIE INC. | $20.39 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359755 | CMS |
| ABBVIE INC. | $5.86 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359757 | CMS |
| ABBVIE INC. | $5.46 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359759 | CMS |
| ABBVIE INC. | $22.92 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359761 | CMS |
| ABBVIE INC. | $23.80 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359763 | CMS |
| ABBVIE INC. | $25.16 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359765 | CMS |
| ABBVIE INC. | $8.17 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359767 | CMS |
| ABBVIE INC. | $11.78 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359769 | CMS |
| ABBVIE INC. | $24.75 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359771 | CMS |
| ABBVIE INC. | $24.78 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359773 | CMS |
| ABBVIE INC. | $18.03 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359775 | CMS |
| ABBVIE INC. | $21.42 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359777 | CMS |
| ABBVIE INC. | $18.79 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359779 | CMS |
| ABBVIE INC. | $14.07 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359781 | CMS |
| Amgen Inc. | $13.35 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117498970 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.60 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118209157 | CMS |
| Galderma Laboratories, L.P. | $17.69 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145365091 | CMS |
| Kerecis Limited | $25.11 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120097055 | CMS |
| LEO Pharma Inc. | $21.14 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152671895 | CMS |
| Novartis Pharmaceuticals Corporation | $21.14 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086944663 | CMS |
| Novartis Pharmaceuticals Corporation | $25.86 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086944673 | CMS |
| PFIZER INC. | $25.44 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131432102 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.